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Abstract: Turkey is located adjacent to the regions of war and
crisis. After the outbreak of conﬂicts in Syria on March 2011, over
4.5 million people have been forced to leave their country and
over 2,200,000 of them took refuge in Turkey. Turkish government
has implemented “open-door policy” and shouldered a tremen-
dous load collaborating with non-governmental organizations and
spent nearly $8 billion for caring of refugee population. Refugees
were ﬁrst met at border crossing points, registered and given iden-
tity cards that document the status of “temporary protection”. A
symptom-based screening (not a standard protocol) was imple-
mented forurgenthealthproblemsduring registrationandchildren
were included in the national vaccination program comprising oral
polio, measles (MMR),TdaP-HiB-IPV(quintet vaccine), hepatitis-B
and conjugated pneumococcus.
As of January 4, 2016; 267,476 refugees are placed in 25 sepa-
rate accommodation centers in ten different cities and remaining
majority of refugees live out of the camps. Although health and
education facilities are better in the camps, those non-camp res-
idents also have free access to primary care and even secondary
or tertiary-care if address-based registry was made and complied
to the referral chain. Mop-up vaccination campaigns are launched
for non-camp residents scattered in large cities and the coverage
has extended above 90 percent for polio and measles. Healthcare
capacity for refugees/asylum seekers was re-established by recent
regulations on the basis of “Law on foreigners and international
protection” that has entered into force on 11 April 2014. According
to the current legislation; medical requirements of Syrian refugees
including medicine, dentures, eyeglasses, hearing aids and similar
medical materials are provided, treatment costs are to be billed to
the Governor of the relevant province.
A signiﬁcant number of the refugees suffer physical and psy-
chological traumas of the war while infections are not among the
leading health problems. According to the records of Ministry of
Health; 5505 cases of cutaneous leismaniasis and 558 cases of
tuberculosis were detected and treated (in and out of the camps) as
of October 2015. Tuberculosis was screened in 10,689 refugees and
the prevalence was found to be similar to the Turkish population
(18.7/100 000). Screening was terminated. No case of malaria was
detected in the blood smears of over 100,000 people. A signiﬁcant
increase was detected in cases of measles, particularly in south-
eastern region where the camps are located. This caused a shift in
national vaccination program and the booster of MMR vaccine was
withdrawn from the ﬁrst year of primary school to the preschool
period.
Breakdown of healthcare infrastructure, shortage of medical
personnel, medical supply and drugs, limited access to clean water
and problems with garbage disposal had lead to outbreaks of hep-
atitis A, typhoid fever and cholera in Syria. Increasing number of
cutaneous leishmaniasis cases in Turkey and Lebanon, tuberculo-
sis in Lebanon and Jordan among refugees was reported. Overall
due to the lack of infrastructure of health care system in Syria,
increasing number of refugees and overcrowded camps with sub-
optimal sanitation conditions in Lebanon and Iraq, these emerging
and re-emerging pathogens not only threat the refugees but also
effect the citizens ofMiddle East countries and even Europe. There-
fore there is an urgent need of international collaboration between
United Unions, European Union, governments, WHO, CDC, ECDC,
humanitarian organizations, funding bodies and pharmaceutical
companies to copewith infectiousdiseases, humanitariancrisis and
recover health care and public health system in Syria.
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Abstract: One of the deﬁnitions of diagnostic point of care
testing is provision of laboratory testing at or near the site of
patient care. It has the potential to minimise the time to obtain
the result of the test, which expedites the diagnosis and initia-
tion of the treatment especially in resource-limited settings where
health care infrastructure is weak and access to quality and timely
medical care represents a challenge. It is estimated, that intro-
duction of rapid, laboratory-independent diagnostic tests for four
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diseases (syphilis, malaria, tuberculosis and bacterial pneumonia)
in developing countries could preventmore than 1.2million deaths
annually. In resource-limited settings, laboratory medicine is still
one of themost neglected pillars of the health care. In such settings,
primary health care services largely depend on diagnostic point of
care testing; therefore the beneﬁts need to overweight the costs.
To optimise the diagnostic point-of-care, there is a need for strict
evaluation focused on relevant clinical outcomes and operational
costs and these evaluations differ from the conventional tests.
However, there is no consistent, standardized approach to assess
the point-of-care testing technologies in resource-limited settings.
Diagnostic point-of-care testing possesses signiﬁcant importance
in infections like TB or HIV, because it eliminates the long turn-
around times and delays and the resulting loss of patients from
the testing and therapy pathway. An ideal rapid diagnostic point-
of-care test used in resource-limited settings should fulﬁl the
following criteria: allowing a quick clinical decision, can be used
by a health careworker (possibly by a nonprofessional), affordable,
rapid, acceptable test efﬁcacy, and cost effectiveness.
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Abstract: Migrant Crisis in Europe 2015 had two major routes,
Balkan route via Greece, Hungary, Austria to Germany and African
route with mainly economic refugees and migrants via Mediter-
ranean Malta Lampedusa, Sicily to continental Italy, France, Spain
and UK. Here we present ﬁrst data on migrant health of the Balkan
route from September to October 2015.
About 316 000 political and humanitarian refugees, 95% from
Syria, Iraq and Afganistan passed through checkpoint Hegye-
shalom, Nickelsdorf 50 km east from Vienna and 10 km from
Bratislava, between September 6th andOctober 20th.Most of them
were healthy young peoplewith children, about 10 percent sick per
transport, in 97 trains from Zakanyi Croatian Boundary or Röszke,
HU- Serbian Boundary to Hegyeshalom, Nickelsdorf HU, AT check-
point. Sick patient’s reported themselves to the symptomatic ﬁeld
heath center with 8-12 HC Tropicteam staff serving in 5 languages.
In RTI patients, nasal/tonsil swabs was taken to Mueller Hinton
agar and transported toNational referenceLaboratory forATB resis-
tance, Nitra, SK.
No major tropical diseases were noted, no case of malaria or
leishmaniasis was detected. Even less cases of emerging ID includ-
ing HIV and tuberculosis were detected as well. Majority of ID
included pneumonia upper respiratory tract infections, skin and
soft tissue infections, scabies, few cases (<3%) of diarrhoea but no
case of cholera have been observed in described period. Among
acute cases, diabetic coma, myocardial infarction, hypertension
crisis and has been noted. From 155 positive results from bacteri-
ology from migrants, only 2 MRSA strains and 3 penicillin resistant
pneumococci were obtained, the rest was commensal bacterial
ﬂora and Candida albicans.
Balkan route in refugee crisis in 2016 in Europe from Syria,
Iraq does not represent major health threat to continental EU, only
few cases of transmissible diseases were noted and an absence of
tropical diseases, multiresistant pathogens and no outbreaks were
observed within ﬁrst 2 months of exodus. Only few MRSA and
penicillin resistant strains from patients from upper and lower res-
piratory tract infections were isolated. Spectrum of diagnoses was
similar to surrounding Slovak, Hungarian and Austrian population
of that EU region.
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Background: Visceral leishmaniasis (VL), or Kala-Azar is a life-
threatening systemic infection caused by protozoan Leishmania,
with sandﬂies as its vectors affecting thepoorest of thepoorpeople.
Indiabears50%of globalVLburdenandwascommitted toeliminate
VL elimination by 2015. New treatment modalities were proposed
by WHO since 2010, yet ﬁrst line treatment in India has remained
unchanged since 2006. The 2014 release of India National Road
Map of Kala azar Elimination marked a milestone in the progress
towards the elimination goal: Single Dose liposomal amphotericin
B (Ambisome®) or SDA was adopted in the national programme.
Role of evidence in the policy change is explored.
Methods & Materials: Médecins Sans Frontières (MSF) started
a VL treatment programme in Bihar, India since 2007, using 20
mg/kg intravenous Ambisome and treated over 11,000 patients
with excellent results. With lack of high quality evidence, a phase
4 trial of new treatmentmodalities including SDAwas commenced
inAugust 2012byMSF, Drug forNeglecteddisease initiative (DNDi)
andRajendraMemorial research Institute (RMRI). Effectiveness and
safety data presented in December 2013. Additionally, a qualitative
study to determine patient perspectives of these new treatments
was conducted. At the same time, advocacywise, a successful nego-
tiation with Gilead as Ambisome producer has led to free donation
of the drug to the Indian Government, further facilitating the pro-
cess towards policy change.
Results: By supporting MoH facilities in implementing alterna-
tive regimen such as Ambisome, MSF demonstrated its feasibility
at different level of health care, including primary health centres.
Evidence from formal trial is indispensable; however, debunking
the perception that such a ‘complex’ treatment could not be imple-
mented as ﬁrst line treatment was as important. Various factors
